Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom

Endoscopic Submucosal Dissection in the Treatment of Early Gastrointestinal Neoplasia: A UK Cohort Study to Assess Effectiveness and Safety

Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.

Data will be collected from participating centres on en bloc resection, curative resection, R0 resection and complications/adverse events over a 2 year follow up period.

Demographic details on the patients included in the study will be captured alongside details on the size and location of their early gastrointestinal dysplastic/neoplastic lesions.

Inclusion Criteria:

• Male or Female, aged 18 years or above undergoing endoscopic submucosal dissection
• Participant is able to give informed consent for participation in the study

Exclusion Criteria:

• Patients under the age of 18
• Patients unable to give informed consent